ABOS

0.170311.90%
JD

James Doherty

President & Chief Development Officer

Dr. James Doherty, also known as Jim, Ph. D., serves as President & Chief Development Officer at Acumen Pharmaceuticals, Inc. since February 2024. He served as Chief Development Officer at Sage Therapeutics, Inc. since November 2021 until August 2023. He served as Chief Research Officer at Sage Therapeutics Inc since October 2018 until November 2021. He served as the Senior Vice President of Research at Sage Therapeutics, Inc. since September 21, 2015 until October 2018. Dr. Doherty served as Vice President of Pharmacology and Head of Biology at Sage Therapeutics, Inc. He joined SAGE in 2012. Prior to, he served as Director and Head of the Neuroscience Department for the CNS and Pain Innovative Medicine Unit of AstraZeneca Pharmaceuticals in Sodertalje, Sweden. Prior to, he SERVEDA S Director and Head of the Neuroscience Department at AstraZeneca Pharmaceuticals in Wilmington, Del. He has experience with discovery, translational science and early development in several areas of neuroscience research, including psychiatry, neurology, cognition, epilepsy and analgesia. He has authored more than 30 peer-reviewed research and review articles. He was a postdoctoral fellow at Emory University Medical School. Dr. Doherty holds a B. A. in biology from the University of Delaware and a Ph. D. in neuroscience from Georgetown University.

Positions